CompletedPhase 1NCT00049400
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Angela Davies, MDUniversity of California, Davis
- Intervention
- BMS-247550(drug)
- Enrollment
- 78 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2003 – 2007
Study locations (23)
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
- University of California Davis Cancer Center, Sacramento, California, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, United States
- Case Comprehensive Cancer Center, Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
- Community Oncology Group at Cleveland Clinic Cancer Center, Independence, Ohio, United States
- Cleveland Clinic - Wooster, Wooster, Ohio, United States
- Brooke Army Medical Center, Fort Sam Houston, Texas, United States
- Wilford Hall Medical Center, Lackland Air Force Base, Texas, United States
- University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
- St. Joseph Hospital Community Cancer Center, Bellingham, Washington, United States
- Olympic Hematology and Oncology, Bremerton, Washington, United States
- Skagit Valley Hospital Cancer Care Center, Mount Vernon, Washington, United States
- +8 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00049400 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University